World's Best Scientists 2026 revealed!
Award Badge
Medicine
Spain
2023

D-Index & Metrics

Medicine

D-Index
124
Citations
195436
World Ranking
3137
National Ranking
41

Luis M. Ruilope publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Luis M. Ruilope sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,281 publications — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Luis M. Ruilope D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Luis M. Ruilope sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 124 D-Index — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Medicine in Spain Leader Award

Overview

Luis M. Ruilope is affiliated with the European University of Madrid in Spain and has an extensive research portfolio in the field of Medicine, with a particular focus on Cardiology and Cardiovascular Medicine. Their work spans subfields such as Endocrinology, Diabetes and Metabolism, Nephrology, Surgery, and Pulmonary and Respiratory Medicine.

Their main research topics include Blood Pressure and Hypertension Studies, Hormonal Regulation and Hypertension, Heart Rate Variability and Autonomic Control, Diabetes Treatment and Management, Cardiovascular Health and Disease Prevention, Diet and Metabolism Studies, and Chronic Kidney Disease and Diabetes.

Luis M. Ruilope has published notable papers including:

  • Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC, 2021, PubMed
  • Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes, 2020, New England Journal of Medicine
  • Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis, 2021, European Heart Journal
  • Lifestyle interventions for the prevention and treatment of hypertension, 2020, Nature Reviews Cardiology
  • Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes, 2020, Circulation

The scientist frequently publishes in the following venues:

  • Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature
  • Journal of Hypertension
  • European Heart Journal
  • Journal of the American College of Cardiology
  • Journal of the American Society of Nephrology

Frequent collaborators in Luis M. Ruilope's work include:

  • Peter Rossing
  • Stefan D. Anker
  • Gerasimos Filippatos
  • Gema Ruiz-Hurtado
  • Bertram Pitt

Best Publications

  • 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

    Piotr Ponikowski;Adriaan A Voors;Stefan D Anker;Héctor Bueno

  • 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

    Giuseppe Mancia;Robert Fagard;Krzysztof Narkiewicz;Josep Redon

  • 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

    Piotr Ponikowski;Adriaan A. Voors;Stefan D. Anker;Héctor Bueno

  • 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

    Giuseppe Mancia;Robert Fagard;Krzysztof Narkiewicz;Josep Redon

  • 2007 Guidelines for the management of arterial hypertension

    Giuseppe Mancia;Guy De Backer;Anna Dominiczak;Renata Cifkova

  • 2007 Guidelines for the Management of Arterial Hypertension : The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

    Giuseppe Mancia;Guy De Backer;Anna F. Dominiczak;Renata Cifkova

  • European guidelines on cardiovascular disease prevention in clinical practice (version 2012) : the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).

    J Perk;G De Backer;H Gohlke;I Graham

  • Reappraisal of European guidelines on hypertension management:: A European Society of Hypertension Task Force document

    Giuseppe Mancia;Stéphane Laurent;Enrico Agabiti-Rosei;Ettore Ambrosioni

  • Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): A randomised controlled trial

    Murray D. Esler;Henry Krum;Paul A. Sobotka;Markus P. Schlaich

  • 2018 ESC/ESH Guidelines for the management of arterial hypertension : The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension

    Bryan Williams;Giuseppe Mancia;Wilko Spiering;Enrico Agabiti Rosei

  • 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension.

    Giuseppe Mancia;Guy De Backer;Anna Dominiczak;Renata Cifkova

  • European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).

    Ian Graham;Dan Atar;Knut Borch-Johnsen;Knut Borch-Johnsen;Gudrun Boysen

  • Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)

    Morris J Brown;Christopher R Palmer;Alain Castaigne;Peter W de Leeuw

  • Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes

    George L Bakris;Rajiv Agarwal;Stefan D Anker;Bertram Pitt

  • European Society of Hypertension Position Paper on Ambulatory Blood Pressure Monitoring

    Eoin O’Brien;Gianfranco Parati;George Stergiou;Roland Asmar

  • 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension.

    Giuseppe Mancia;Robert Fagard;Krzysztof Narkiewicz;Josep Redán

  • Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes

    Hermann Haller;Sadayoshi Ito;Joseph L. Izzo;Andrzej Januszewicz

  • European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring.

    Gianfranco Parati;George S. Stergiou;Eoin O'Brien;Roland P Asmar

  • Clinical Features of 8295 Patients With Resistant Hypertension Classified on the Basis of Ambulatory Blood Pressure Monitoring

    Alejandro de la Sierra;Julián Segura;José R. Banegas;Manuel Gorostidi

  • 2013 ESH/ESC Practice guidelines for the management of arterial hypertension

    Giuseppe Mancia;Robert Fagard;Krzysztof Narkiewicz;Josep Redon

Frequent Co-Authors

José R. Banegas
José R. Banegas Autonomous University of Madrid
Roland E. Schmieder
Roland E. Schmieder University of Erlangen-Nuremberg
Giuseppe Mancia
Giuseppe Mancia University of Milano-Bicocca
Josep Redon
Josep Redon University of Valencia
Alberto Zanchetti
Alberto Zanchetti University of Milan
Sverre E. Kjeldsen
Sverre E. Kjeldsen University of Oslo
Bernard Waeber
Bernard Waeber University of Lausanne
Stéphane Laurent
Stéphane Laurent Université Paris Cité
Anna F. Dominiczak
Anna F. Dominiczak University of Glasgow
Michel Burnier
Michel Burnier University of Lausanne

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine goes beyond a traditional MD. Today, aspiring healthcare professionals can access numerous accredited online degree programs, allowing for career advancement and specialization while balancing life commitments.

Those interested in healthcare management may consider the cheapest online mha programs, which offer foundational skills in leadership, policy, and administration. For advanced clinical practice, many nurses are now pursuing their doctorates—options such as the least expensive dnp programs provide flexible, affordable solutions.

Pharmacists also have pathways for online learning. Prospective students can enroll in online pharmacy school programs to develop expertise in pharmaceuticals and patient care without attending campus full-time.

Meanwhile, those intrigued by the management of patient data and health technology should explore him programs. These programs prepare graduates for roles at the intersection of health, data, and information systems.

Whether you’re considering patient care, administration, or information management, these affordable online degrees open doors to fast-growing healthcare careers.

Best Scientists Citing Luis M. Ruilope

Trending Scientists

Recently Published Articles